
|Articles|August 15, 2003
Latanoprost joins Pfizer's prescription card plan
New York-With the recent acquisition of Pharmacia Corp., Pfizer Inc. is making latanoprost ophthalmic solution (Xalatan) and three non-ophthalmic medicines available at a reduced cost to qualified senior citizens.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Rayner announces Sophi Phaco System in the US
2
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
3
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
4
PRIMA retinal implant restores vision in patients with advanced GA
5














































